Coronavirus: China Approves Two Vaccines For Clinical Trials

 Coronavirus: China Approves Two Vaccines For Clinical Trials

Medical personnel in protective suits prepare traditional Chinese medicine (TCM) for patients of the novel coronavirus with an intelligent dispensing equipment at a pharmacy of Wuhan Tongji Hospital in Wuhan, the epicentre of the novel coronavirus outbreak, in Hubei province, China March 2, 2020. China Daily via REUTERS ATTENTION EDITORS – THIS IMAGE WAS PROVIDED BY A THIRD PARTY. CHINA OUT. – RC2OBF9XSLRE

China has approved two experimental vaccines against the Coronavirus for phase one and two clinical trials.

According to the country’s news agency, Xinhua, the vaccines are being developed by Wuhan Institute of Biological Products under the China National Pharmaceutical Group (Sinopharm) and Sinovac Research and Development Co., Ltd, a company based in Beijing.

Clinical trials of the first vaccine developed in China began in mid-March, with 108 volunteers taking part in them.

However, one of the Chinese medical experts had earlier warned that the Coronavirus infection vaccine currently being developed by China is just entering the first phase of the clinical trials, and it will probably take more than a year to finish it.

Related post

Leave a Reply

%d bloggers like this: